3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
87
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Recurrence
16
Burkitt Lymphoma
13
Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Immunoglobulin Light-chain Amyloidosis
6
Neoplasms, Plasma Cell
5
Leukemia
5
Hodgkin Disease
5
Smoldering Multiple Myeloma
4
Carcinoma, Non-Small-Cell Lung
4
Waldenstrom Macroglobulinemia
3
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Nausea
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Brain Neoplasms
3
Renal Insufficiency
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell
2
Leukemia, Plasma Cell
2
Interventions
Magnetic Resonance Spectroscopy
19
Temozolomide
16
Radiotherapy
10
Specimen Handling
7
Blood Specimen Collection
7
Radiation
6
Bevacizumab
5
Nivolumab
4
Cyclophosphamide
4
Biopsy
4
vorasidenib
3
trametinib
3
pembrolizumab
3
olaparib
3
fludarabine
3
dabrafenib
3
Watchful Waiting
3
Surgical Procedures, Operative
3
Magnetic Resonance Imaging
3
Drug Therapy
3
olutasidenib
2
lutetium Lu 177 dotatate
2
fluorodopa F 18
2
fluciclovine F-18
2
entrectinib
2
contrast agent BR1
2
Restraint, Physical
2
Radiosurgery
2
Microdialysis
2
Flucytosine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Glioma
×
Dexamethasone
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled